These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30398909)

  • 21. Abscisic acid ameliorates oxidative stress, inflammation, and apoptosis in thioacetamide-induced hepatic fibrosis by regulating the NF-кB signaling pathway in mice.
    Chen X; Ding C; Liu W; Liu X; Zhao Y; Zheng Y; Dong L; Khatoon S; Hao M; Peng X; Zhang Y; Chen H
    Eur J Pharmacol; 2021 Jan; 891():173652. PubMed ID: 33069671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of Solanum nigrum on thioacetamide-induced liver fibrosis in mice.
    Hsieh CC; Fang HL; Lina WC
    J Ethnopharmacol; 2008 Sep; 119(1):117-21. PubMed ID: 18606216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dehydrozingerone ameliorates thioacetamide-induced liver fibrosis via inhibition of hepatic stellate cells activation through modulation of the MAPK pathway.
    Sharma N; Shaikh TB; Eedara A; Kuncha M; Sistla R; Andugulapati SB
    Eur J Pharmacol; 2022 Dec; 937():175366. PubMed ID: 36375494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caffeine prevents experimental liver fibrosis by blocking the expression of TGF-β.
    Arauz J; Zarco N; Segovia J; Shibayama M; Tsutsumi V; Muriel P
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):164-73. PubMed ID: 23903851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effects of melatonin against thioacetamide-induced liver fibrosis in rats.
    Czechowska G; Celinski K; Korolczuk A; Wojcicka G; Dudka J; Bojarska A; Reiter RJ
    J Physiol Pharmacol; 2015 Aug; 66(4):567-79. PubMed ID: 26348081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin inhibits mTOR-HIF-1α axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations.
    Al-Hashem F; Al-Humayed S; Amin SN; Kamar SS; Mansy SS; Hassan S; Abdel-Salam LO; Ellatif MA; Alfaifi M; Haidara MA; Al-Ani B
    J Cell Physiol; 2019 Jun; 234(6):9328-9337. PubMed ID: 30334569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMP-activated protein kinase activator, HL156A reduces thioacetamide-induced liver fibrosis in mice and inhibits the activation of cultured hepatic stellate cells and macrophages.
    Lee HS; Shin HS; Choi J; Bae SJ; Wee HJ; Son T; Seo JH; Park JH; Kim SW; Kim KW
    Int J Oncol; 2016 Oct; 49(4):1407-14. PubMed ID: 27498767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cilostazol attenuates indices of liver damage induced by thioacetamide in albino rats through regulating inflammatory cytokines and apoptotic biomarkers.
    El Awdan SA; Amin MM; Hassan A
    Eur J Pharmacol; 2018 Mar; 822():168-176. PubMed ID: 29355562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatoprotective effect of Baicalin against thioacetamide-induced cirrhosis in rats: Targeting NOX4/NF-κB/NLRP3 inflammasome signaling pathways.
    Zaghloul RA; Zaghloul AM; El-Kashef DH
    Life Sci; 2022 Apr; 295():120410. PubMed ID: 35182557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. M1- and M2-macrophage polarization in rat liver cirrhosis induced by thioacetamide (TAA), focusing on Iba1 and galectin-3.
    Wijesundera KK; Izawa T; Tennakoon AH; Murakami H; Golbar HM; Katou-Ichikawa C; Tanaka M; Kuwamura M; Yamate J
    Exp Mol Pathol; 2014 Jun; 96(3):382-92. PubMed ID: 24747241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression.
    Eraky SM; El-Mesery M; El-Karef A; Eissa LA; El-Gayar AM
    Biomed Pharmacother; 2018 May; 101():49-57. PubMed ID: 29477472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of zinc oxide nanoparticles in alleviating hepatic fibrosis and nephrotoxicity induced by thioacetamide in rats.
    Bashandy SAE; Alaamer A; Moussa SAA; Omara EA
    Can J Physiol Pharmacol; 2018 Apr; 96(4):337-344. PubMed ID: 28813612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of armepavine against hepatic fibrosis induced by thioacetamide in rats.
    Weng TC; Shen CC; Chiu YT; Lin YL; Huang YT
    Phytother Res; 2012 Mar; 26(3):344-53. PubMed ID: 21717514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
    Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
    Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of fibrosis/cirrhosis by Glycine propionyl-l-carnitine treatment in d-Galactosamine induced chronic liver damage.
    Ganai AA; Ganaie IA; Verma N; Farooqi H
    Chem Biol Interact; 2016 Dec; 260():117-128. PubMed ID: 27836788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dual PPAR-α/γ agonist saroglitazar ameliorates thioacetamide-induced liver fibrosis in rats through regulating leptin.
    Makled MN; Sharawy MH; El-Awady MS
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1569-1576. PubMed ID: 31367862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis.
    Shaker ME; Shiha GE; Ibrahim TM
    Eur J Pharmacol; 2011 Nov; 670(2-3):593-600. PubMed ID: 21925495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-fibrotic effects of Cuscuta chinensis with in vitro hepatic stellate cells and a thioacetamide-induced experimental rat model.
    Kim JS; Koppula S; Yum MJ; Shin GM; Chae YJ; Hong SM; Lee JD; Song M
    Pharm Biol; 2017 Dec; 55(1):1909-1919. PubMed ID: 28651481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yohimbine ameliorates liver inflammation and fibrosis by regulating oxidative stress and Wnt/β-catenin pathway.
    Sharma N; Sistla R; Andugulapati SB
    Phytomedicine; 2024 Jan; 123():155182. PubMed ID: 37952411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: an insight.
    Shiha GE; Abu-Elsaad NM; Zalata KR; Ibrahim TM
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):788-97. PubMed ID: 25115651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.